Chenghao Fu

Chenghao Fu

Auto-generated profile, based on publicly available information

Chenghao Fu

College of Bioscience and Biotechnology, Shenyang Agricultural University, Shenyang 110866, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
BZBochuan Zhang
Bochuan Zhang
QWQingfeng Wang
Qingfeng Wang
CFChenghao Fu
Chenghao Fu
CJChunying Jiang
Chunying Jiang
MSMa Shiliang
Ma Shiliang
Background: In this study, we aimed to explore the tumour associated immune signature of breast cancer (BC) and conduct integrative analyses with immune infiltrates in BC. Methods: We downloaded the transcriptome profiling and clinical data of BC from The Cancer Genome Atlas (TCGA) database. The list of immune-related signatures was from the Innate database. The limma package was utilized to conduct the normalization, and we screened the differential immune signatures in BC. A univariate Cox regression model and the LASSO method were used to find the hub prognostic immune genes. The TAIG risk model was calculated based on the multivariate Cox regression results, and a receiver operating characteristic (ROC) curve was generated to assess the predictive power of TAIG. Moreover, we also conducted a correlation analysis between TAIG and the clinical characteristics. Additionally, we utilized the METABRIC cohort as the validation data set. The TIMER database is a comprehensive resource for performing systematic analyses of immune infiltrates across various malignancies. We evaluated the associations of immune signatures with several immune cells based on TIMER. Furthermore, we used the CIBERSORT algorithm to determine the fractions of immune cells in each sample and compared the differential distributions of immune infiltrates between two TAIG groups using the Wilcoxon rank-sum test. Results: A total of 1,178 samples were obtained from the TCGA-BRCA database, but only 1,045 breast tumour samples were matched with complete transcriptome expression data. Meanwhile, we collected a total of 1,094 BC patients from the METABRIC cohort. We found a list of 1,399 differential immune signatures associated with survival, and functional analysis revealed that these genes participated in cytokine-cytokine receptor interactions, Th1 and Th2 cell differentiation and the JAK-STAT signalling pathway. The TAIG risk model was established from the multivariate Cox analysis, and we observed that high TAIG levels correlated with poor survival outcomes based on Kaplan-Meier analysis. The Kruskal-Wallis test suggested that high TAIG levels correlated with high AJCC-TNM stages and advanced pathological stages (P<0.01). We validated the well robustness of TAIG in METABRIC cohort and 5-year AUC reached up to 0.829. Moreover, we further uncovered the associations of hub immune signatures with immune cells and calculated the immune cell fractions in specific tumour samples based on gene signature expression. Last, we used the Wilcoxon rank-sum test to compare the differential immune density in the two groups and found that several immune cells had a significantly lower infiltrating density in the high TAIG groups, including CD8+ T cells (P=0.031), memory resting CD4+ T cells (P=0.026), M0 macrophages (P=0.023), and M2 macrophages (P=0.048). Conclusions: In summary, we explored the immune signature of BC and constructed a TAIG risk model to predict prognosis. Moreover, we integrated the identified immune signature with tumour-infiltrating immune cells and found adverse associations between the TAIG levels and immune cell infiltrating density.

1 September 2017 in Electronic Journal of Biotechnology
Verified
Journal Article
Open access
XYXiao-Chun Yu
Xiao-Chun Yu
SMShi-Liang Ma
Shi-Liang Ma
YXYan Xu
Yan Xu
CFCheng-Hao Fu
Cheng-Hao Fu
CJChun-Ying Jiang
Chun-Ying Jiang
CZChen-Yu Zhou
Chen-Yu Zhou
Background: We aimed to test the possibility of improving polypeptide production from soybean meal fermentation by engineered Aspergillus oryzae strains. Four different protease genes were cloned and transformed into wild-type A. oryzae, and the engineered A. oryzae strains were then used for soybean meal fermentation. Results: The results showed different degrees of improvement in the protease activity of the four transformants when compared with wild-type A. oryzae. A major improvement in the polypeptide yield was achieved when these strains were used in soybean meal fermentation. The polypeptide conversion rate of one of the four transformants, A. oryzae pep, reached 35.9%, which was approximately twofold higher than that exhibited by wild-type A. oryzae. Amino acid content analysis showed that the essential amino acid content and amino acid composition of the fermentation product significantly improved when engineered A. oryzae strains were used for soybean meal fermentation. Conclusions: These findings suggest that cloning of microbial protease genes with good physicochemical properties and expressing them in an ideal host such as A. oryzae is a novel strategy to enhance the value of soybean meal

1 January 2018 in Food and Agricultural Immunology
Verified
Journal Article
Open access
KZKexin Zheng
Kexin Zheng
CFChenghao Fu
Chenghao Fu
CJChunying Jiang
Chunying Jiang
Xiqing YueXiqing Yue
Xiqing Yue
MSMa Shiliang
Ma Shiliang
Pilose antler (PA) is used to treat many diseases, but its effect on breast cancer is still unclear. Here, we report the effects of PA on the growth of the mouse mammary tumour in vitro and in vivo, and its effects on immune system of the tumor-bearing mice. The 4T1 mouse mammary tumour cells were cultured with media supplemented with water extract of PA (WEPA), and the female BALB/c mice transplanted with 4T1 cells were treated by gavage with WEPA. The results showed that WEPA promoted the proliferation of 4T1 cells in vitro, while inhibited the growth of 4T1 tumour in vivo. In addition, WEPA increased the proportion of CD4+ T cells, CD8+ T cells and NK cells and reduced myeloid-derived suppressive cells in mouse peripheral blood. These results suggest that WEPA can inhibit the growth of mouse 4T1 tumours through modulating immune system of the mouse.

16 November 2018 in Natural Product Research
Verified
Journal Article
Closed access
DZDayu Zhou
Dayu Zhou
CJChunying Jiang
Chunying Jiang
CFChenghao Fu
Chenghao Fu
PCPing Chang
Ping Chang
BYBin Yang
Bin Yang
MSMa Shiliang
Ma Shiliang
This study aims to isolate the potential antiproliferative and cytotoxic compounds from ginkgo biloba sarcotestas (GBS) and investigates the underlying mechanism in human MDA-MB-231 and mouse 4T-1 triple-negative breast cancer cells. Our results showed that 2-Hydroxy-6-tridecylbenzoic acid was isolated by cytotoxicity-guided fractionation where different fractions were assessed using MTT assay against MDA-MB-231 and 4T-1 cells. Colony formation assay showed that 2-Hydroxy-6-tridecylbenzoic acid significantly inhibited cell proliferation. The inhibition was associated with the enhancement of cytochrome P450 (CYP) 1B1 expression in a dose- and time-dependent manner and no significant change of CYP1A1 expression by qPCR and Western blot assays in MDA-MB-231 and 4T-1 cells. The mechanism was further demonstrated by the activation of aryl hydrocarbon receptor (AhR) pathway with the upregulation of AhR, AhR nuclear translocator (ARNT) and AhR-dependent xenobiotic response elements (XRE) activity. These findings may have implications for development of anticancer agents containing 2-Hydroxy-6-tridecylbenzoic acid as functional additives.

10 January 2017 in Biotechnology Journal International
Verified
Journal Article
Open access
PDF file
KZKexin Zheng
Kexin Zheng
QLQilong Li
Qilong Li
CFChenghao Fu
Chenghao Fu
SMShiliang Ma
Shiliang Ma
Aims: One of serious threats to women's health is mammary cancer whose occurrence, development, and treatment are related to the body’s immunological circumstances. In addition, the cancer also imposes the some effects on the body’s immune system. However, the body’s response is very diverse because it varies from type to type of cancer. This paper reported that the effects of 4T1 cell transplantation on immune cells and spleen in mice. Methods: Twenty female BALB/C mice were randomly divided into a control group and transplantation group. 4T1 cells were injected into the forth mammary fat pad to construct an animal model of breast cancer metastasis. The lymphocytes from mouse peripheral blood after transplantation and were analyzed by flow cytometry. Results: The transplantation of 4T1 cells rapidly and continuously decreased the percentages of total T cells, total B cells, cytotoxic T cells and helper T cells in peripheral blood during experimental period (28 days). In addition, memory T cells in the transplantation group were increased at 28 days after transplantation. Only the natural killer (NK) cell percentage was significantly increased at 14 days after transplantation. Conclusions: 4T1 cell transplantation exerted distinctive effects on the different types of immune cells in mouse peripheral blood: the transplantation of 4T1 cells decreased the levels of total T cells, total B cells, cytotoxic T cells, helper T cells and memory T cells, and the natural killer (NK) cell was increased transiently than in control group.

12 February 2019 in Gene
Verified
Journal Article
Open access
YLYao Lu
Yao Lu
QLQilong Li
Qilong Li
KZKexin Zheng
Kexin Zheng
CFChenghao Fu
Chenghao Fu
CJChunying Jiang
Chunying Jiang
MSMa Shiliang
Ma Shiliang
In metazoan genome, the mechanism of gene expression regulation between transcriptional regulatory elements and their target gene is spatiotemporal. Active promoters possess many specific chromosomal features, such as hypersensitive to DNaseI and enrichment of specific histone modifications. In this article, we proposed a novel method which possesses a high efficiency to find promoters in vitro. A promoter-trap library was constructed with totally 706 random mouse genomic DNA fragment clones, and 260 promoter-active fragments of the library were screened by transient transfection into 4T1 cells. To demonstrate the accuracy of this promoter finding method, 13 fragments with promoter activities were randomly selected for published DNase-seq and ChIP-seq data analysis, downstream transcripts prediction and expression confirmation. qRT-PCR results showed that six predicted transcription units were successfully amplified in different mouse tissues/cells or in reconstituted mouse mammary tumors. Our results indicate that this promoter finding method can successfully detect the promoter-active fragments and their downstream transcripts.